Calcitriol
Internal ID | ff5abd37-f1d7-43ec-ac92-7e14a93347a2 |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Vitamin D and derivatives |
IUPAC Name | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol |
SMILES (Canonical) | CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C |
SMILES (Isomeric) | C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C |
InChI | InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1 |
InChI Key | GMRQFYUYWCNGIN-NKMMMXOESA-N |
Popularity | 23,393 references in papers |
Molecular Formula | C27H44O3 |
Molecular Weight | 416.60 g/mol |
Exact Mass | 416.32904526 g/mol |
Topological Polar Surface Area (TPSA) | 60.70 Ų |
XlogP | 5.10 |
Atomic LogP (AlogP) | 5.70 |
H-Bond Acceptor | 3 |
H-Bond Donor | 3 |
Rotatable Bonds | 6 |
32222-06-3 |
Rocaltrol |
Calcijex |
Topitriol |
1alpha,25-Dihydroxyvitamin D3 |
Silkis |
1alpha,25-Dihydroxycholecalciferol |
Soltriol |
Dihydroxyvitamin D3 |
Vectical |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9926 | 99.26% |
Caco-2 | + | 0.5681 | 56.81% |
Blood Brain Barrier | + | 0.7250 | 72.50% |
Human oral bioavailability | + | 0.9000 | 90.00% |
Subcellular localzation | Lysosomes | 0.5400 | 54.00% |
OATP2B1 inhibitior | - | 0.8633 | 86.33% |
OATP1B1 inhibitior | + | 0.8176 | 81.76% |
OATP1B3 inhibitior | + | 0.8460 | 84.60% |
MATE1 inhibitior | - | 1.0000 | 100.00% |
OCT2 inhibitior | - | 0.9250 | 92.50% |
BSEP inhibitior | + | 0.8148 | 81.48% |
P-glycoprotein inhibitior | - | 0.5794 | 57.94% |
P-glycoprotein substrate | + | 0.5139 | 51.39% |
CYP3A4 substrate | + | 0.6241 | 62.41% |
CYP2C9 substrate | - | 0.7968 | 79.68% |
CYP2D6 substrate | - | 0.7741 | 77.41% |
CYP3A4 inhibition | - | 0.8130 | 81.30% |
CYP2C9 inhibition | - | 0.8354 | 83.54% |
CYP2C19 inhibition | - | 0.7796 | 77.96% |
CYP2D6 inhibition | - | 0.9495 | 94.95% |
CYP1A2 inhibition | - | 0.9033 | 90.33% |
CYP2C8 inhibition | - | 0.6074 | 60.74% |
CYP inhibitory promiscuity | - | 0.6175 | 61.75% |
UGT catelyzed | + | 0.6000 | 60.00% |
Carcinogenicity (binary) | - | 0.9400 | 94.00% |
Carcinogenicity (trinary) | Non-required | 0.6277 | 62.77% |
Eye corrosion | - | 0.9918 | 99.18% |
Eye irritation | - | 0.9540 | 95.40% |
Skin irritation | + | 0.5235 | 52.35% |
Skin corrosion | - | 0.9385 | 93.85% |
Ames mutagenesis | - | 0.9400 | 94.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8130 | 81.30% |
Micronuclear | - | 0.9500 | 95.00% |
Hepatotoxicity | - | 0.8322 | 83.22% |
skin sensitisation | - | 0.6213 | 62.13% |
Respiratory toxicity | + | 0.7889 | 78.89% |
Reproductive toxicity | + | 0.9444 | 94.44% |
Mitochondrial toxicity | + | 0.9875 | 98.75% |
Nephrotoxicity | - | 0.8805 | 88.05% |
Acute Oral Toxicity (c) | I | 0.8580 | 85.80% |
Estrogen receptor binding | + | 0.8907 | 89.07% |
Androgen receptor binding | + | 0.8696 | 86.96% |
Thyroid receptor binding | + | 0.7957 | 79.57% |
Glucocorticoid receptor binding | + | 0.6601 | 66.01% |
Aromatase binding | + | 0.5906 | 59.06% |
PPAR gamma | + | 0.6618 | 66.18% |
Honey bee toxicity | - | 0.7891 | 78.91% |
Biodegradation | - | 0.8250 | 82.50% |
Crustacea aquatic toxicity | - | 0.5000 | 50.00% |
Fish aquatic toxicity | + | 0.9931 | 99.31% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
25118.9 nM |
Potency |
via CMAUP
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
22387.2 nM |
Potency |
via CMAUP
|
CHEMBL1977 | P11473 | Vitamin D receptor |
1.13 nM 0.01 nM 0.1 nM 0.35 nM 1.13 nM 0.06 nM 0.08 nM 1.24 nM 0.8 nM 0.7 nM |
IC50 EC50 IC50 IC50 IC50 IC50 IC50 IC50 IC50 IC50 |
via Super-PRED
via Super-PRED PMID: 26613420 PMID: 26613420 PMID: 26562542 PMID: 26515040 PMID: 24742174 PMID: 22989379 PMID: 17924616 PMID: 17149880 |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.70% | 97.25% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 96.27% | 95.93% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 96.11% | 91.11% |
CHEMBL237 | P41145 | Kappa opioid receptor | 94.70% | 98.10% |
CHEMBL2581 | P07339 | Cathepsin D | 93.33% | 98.95% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 93.07% | 96.09% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 93.05% | 97.79% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 92.81% | 93.56% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 92.31% | 97.09% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 90.79% | 94.45% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 90.55% | 95.58% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 89.59% | 95.89% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 89.50% | 100.00% |
CHEMBL206 | P03372 | Estrogen receptor alpha | 88.42% | 97.64% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 88.18% | 90.71% |
CHEMBL1902 | P62942 | FK506-binding protein 1A | 87.84% | 97.05% |
CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 87.68% | 85.31% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 87.39% | 82.69% |
CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 87.24% | 92.88% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 86.52% | 100.00% |
CHEMBL299 | P17252 | Protein kinase C alpha | 85.85% | 98.03% |
CHEMBL233 | P35372 | Mu opioid receptor | 85.02% | 97.93% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 84.90% | 100.00% |
CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 84.51% | 97.47% |
CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 83.81% | 94.78% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 83.59% | 90.17% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 82.53% | 91.03% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.50% | 95.50% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 82.12% | 100.00% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 81.92% | 95.56% |
CHEMBL236 | P41143 | Delta opioid receptor | 81.85% | 99.35% |
CHEMBL2959 | Q08881 | Tyrosine-protein kinase ITK/TSK | 81.57% | 95.00% |
CHEMBL238 | Q01959 | Dopamine transporter | 81.54% | 95.88% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 80.92% | 89.50% |
CHEMBL5203 | P33316 | dUTP pyrophosphatase | 80.77% | 99.18% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 80.66% | 93.00% |
CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 80.30% | 91.07% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 80.25% | 86.33% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 80.01% | 98.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Erycibe expansa |
Solanum glaucophyllum |